Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/5191
DC FieldValueLanguage
dc.contributor.authorNeves, M.-
dc.contributor.authorGano, L.-
dc.contributor.authorPereira, N.-
dc.contributor.authorCosta, M. C.-
dc.contributor.authorCosta, M. R.-
dc.contributor.authorChandia, M.-
dc.contributor.authorRosado, M.-
dc.contributor.authorFausto, R.-
dc.date.accessioned2008-09-01T15:05:31Z-
dc.date.available2008-09-01T15:05:31Z-
dc.date.issued2002en_US
dc.identifier.citationNuclear Medicine and Biology. 29:3 (2002) 329-338en_US
dc.identifier.urihttps://hdl.handle.net/10316/5191-
dc.description.abstractBisphosphonates (BPs) are characterized by a P-C-P backbone structure and two phosphonic acid groups bonded to the same carbon, and are established as osteoclast-mediated bone resorption inhibitors. The nature of the groups attached to the central carbon atom are responsible in determining the potency of bisphosphonates as anti-resorption drugs. However, it is not yet clear the exact relationship between their molecular structure and pharmacologic activities. In this study, molecular geometries of pamidronate, alendronate and neridronate, differing only in the length of the aliphatic chains, were predicted by molecular mechanics and their interactions with hydroxyapatite, the main bone mineral component, were examined. We report the synthesis and radiochemical characterization of 153Sm complexes with pamidronate, alendronate and neridronate. Hydroxyapatite binding and biodistribution studies of these complexes have shown a good correlation with the theoretical molecular modeling interaction studies. So, it is possible to conclude that computational chemistry techniques are a good approach to evaluate specific interactions and may play a relevant role in determining the relative ability of BPs to mineral bone, and open new perspectives to the design of new BPs with increased pharmacological activity. These techniques could be extended to BPs as ligands to carrier radioactive metals, aiming for new bone therapeutic radiopharmaceuticals.en_US
dc.description.urihttp://www.sciencedirect.com/science/article/B6T9Y-45FG7NF-8/1/35a32b5d3765b34f70f226e8330805a1en_US
dc.format.mimetypeaplication/PDFen
dc.language.isoengeng
dc.rightsopenAccesseng
dc.subjectBisphosphonatesen_US
dc.subjectHydroxyapatite bindingen_US
dc.subjectMolecular modelingen_US
dc.subjectTherapeutic radiopharmaceuticalsen_US
dc.titleSynthesis, characterization and biodistribution of bisphosphonates Sm-153 complexes: correlation with molecular modeling interaction studiesen_US
dc.typearticleen_US
dc.identifier.doi10.1016/S0969-8051(01)00305-5-
uc.controloAutoridadeSim-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypearticle-
item.cerifentitytypePublications-
item.grantfulltextopen-
item.fulltextCom Texto completo-
item.languageiso639-1en-
crisitem.author.researchunitCQC - Coimbra Chemistry Centre-
crisitem.author.researchunitCQC - Coimbra Chemistry Centre-
crisitem.author.parentresearchunitFaculty of Sciences and Technology-
crisitem.author.parentresearchunitFaculty of Sciences and Technology-
crisitem.author.orcid0000-0001-5782-8819-
crisitem.author.orcid0000-0002-8264-6854-
Appears in Collections:FCTUC Química - Artigos em Revistas Internacionais
Files in This Item:
File Description SizeFormat
file068a0c124fce4725ad4b199cbe8a4f59.pdf297.68 kBAdobe PDFView/Open
Show simple item record

SCOPUSTM   
Citations

76
checked on Nov 9, 2022

WEB OF SCIENCETM
Citations 50

74
checked on May 2, 2023

Page view(s)

306
checked on Apr 23, 2024

Download(s) 50

607
checked on Apr 23, 2024

Google ScholarTM

Check

Altmetric

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.